Please login to the form below

Not currently logged in
Email:
Password:

European Research Council readies €2bn in science funding

Aims to reward potential breakthrough discoveries

ERCThe European Research Council (ERC) has earmarked €1.86bn for its next Work Programme scheme - a competition intended to give European researchers support to “deliver ground-breaking scientific results”.

There are a total of five grants up for grabs outlined in the programme, with most of the fund reserved for early- to mid- career researchers.

Carlo Moedas, commissioner for research, science and innovation, said: “This is the starting whistle for the next round of this champions’ league of European research within the EU’s Horizon 2020 research and innovation programme.

“I hope this new series of competitions for excellence in science will identify and reward potential breakthroughs, and will be an investment for the future of Europe.”

In addition, the council is also re-introducing the ‘much anticipated’ synergy grants, a funding scheme for groups of two to four scientists who jointly address ‘ambitious’ research problems.

Professor Jean-Pierre Bourguignon, ERC president, said: “These grants can trigger unconventional collaborations, allow for the emergence of new fields of study and help put scientists working in Europe at the global forefront.

“By providing €250m of funding for the Synergy Grant call, the ERC Scientific Council intends to make possible substantial advances at the frontiers of knowledge which would be impossible for researchers working alone.”

The programme includes all of the established ERC funding schemes, including starting, consolidator and advanced grants as well as proof of concept grants for ERC grantees who intend to explore the innovation potential of their research results.

Applications for the starting and synergy competition grants closes on 17 October 2017 and 14 November 2017, respectively.

Article by
Gemma Jones

23rd August 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics